Serum irisin concentration in women with gestational diabetes

Gynecological Endocrinology

Volumn 30, Issue 9, 2014, Pages 636-639

  Kuzmicki, Mariusz ^a   Telejko, Beata ^b   Lipinska, Danuta ^b   Pliszka, Justyna ^a   Szamatowicz, Michal ^a   Wilk, Juliusz ^b   Zbucka Kretowska, Monika ^b   Laudanski, Piotr ^a   Kretowski, Adam ^b   Gorska, Maria ^b   Szamatowicz, Jacek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Endocrinology Diabetology and Internal Medicine ^*  (Poland)

Author keywords

Adipokine; Gestational diabetes; Insulin resistance; Irisin; Myokine; Pregnancy

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; IRISIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SERUM; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GLUCOSE TOLERANCE TEST; PREGNANCY;

ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FEMALE; FIBRONECTINS; GLUCOSE TOLERANCE TEST; HUMANS; PREGNANCY;

EID: 84906269885     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.920006     Document Type: Review

References (22)

1. Boström P, Wu J, Jedrychowski MP, et al. PGC1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-8.
2. Roca-Rivada A, Castelao C, Senin LL, et al. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013; 8: e60563. doi: 10.1371/journal.pone.0060563.
3. Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers and gestational diabetes. Am J Physiol Endocrinol Metab 2014; 306: E512-E518.
4. Schumacher MA, Chinnam N, Ohashi T, et al. The structure of irisin reveals a novel intersubunit b-sheet fibronectin (FNIII) dimer; implications for receptor activation. J Biol Chem 2013; 288: 33738-44.
5. Zhang Y, Li R, Meng Y, et al. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63: 514-25.
6. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013; 98: E769-78.
7. Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 2013; 100: 96-101.
8. Liu JJ, Wong MD, Toy WC, et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 2013; 27: 365-9.
9. Yuksel MA, Oncul M, Tuten A, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract 2014; 104: 171-175.
10. Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care 2007; 30: S105-11.
11. Ebert T, Stepan H, Schrey S, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine 2014; 652: 153-8.
12. Hee Park K, Zaichenko L, Brinkoetter M, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab 2013; 98: 4899-907.
13. Stengel A, Hofmann T, Goebel-Stengel M, et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity -correlation with body mass index. Peptides 2013; 39: 125-30.
14. Staiger H, Böhm A, Scheler M, et al. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One 2013; 8: e61903. doi: 10.1371/journal.pone.0061903.
15. Pekkala S, Wiklund PK, Hulmi JJ, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? J Physiol 2013; 591: 5393-400.
16. Hecksteden A, Wegmann M, Steffen A, et al. Irisin and exercise training in humans - results from a randomized controlled training trial. BMC Med 2013; 11: 235. doi: 10.1186/1741-7015-11-235.
17. Matsuda M, DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-70.
18. Retnakaran R, Qi Y, Goran MI, Hamilton JK. Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 2009; 26: 1198-203.
19. Stancáková A, Javorský M, Kuulasmaa T, et al. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6, 414 Finnish men. Diabetes 2009; 58: 1212-21.
20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-19.
21. Aydin S, Kuloglu T, Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides 2013; 47: 66-70.
22. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61: 1725-38.